Chrysalin: Chrysalis began a Phase I/II trial

Chrysalis BioTechnology Inc., Galveston, Texas Product: Chrysalin synthetic peptide portion of human thrombin Indication: Treat chronic diabetic ulcers Status: Chrysalis began a Phase I/II trial in u...